---
title: Lentiviral Vector Manufacturing CDMOs in Asia-Pacific
path: /services/lentivirus-manufacturing/apac
companies_count: 9
---

# Lentiviral Vector Manufacturing CDMOs in Asia-Pacific

9 published CDMOs match Lentiviral Vector Manufacturing in Asia-Pacific.

Locations in this set include United States, China, Japan, Belgium, Denmark, and Germany.

Capabilities that show up most often in this set: Gene Therapy, Cell Therapy, AAV / Viral Vector Platform, Biologics (Monoclonal Antibodies), and Biologics (Other).

## Matching companies

- [AGC Biologics](/companies/agcbio)
  - Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.
- [Catalent](/companies/catalent)
  - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
- [Charles River Laboratories](/companies/criver)
  - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
- [Hillgene](/companies/hillgene)
  - Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
- [Minaris Advanced Therapies](/companies/wuxi-advanced-therapies)
  - Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Porton Advanced](/companies/porton-advanced)
  - End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe.
- [SK pharmteco](/companies/skpharmteco)
  - SK pharmteco is a CDMO offering comprehensive drug development and manufacturing services.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.